Osteosarcoma Institute
Public records show a registered, tax-exempt organization in good standing.
What it says it does
THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
- Income
- $4.2 million
- Spending
- $2.7 million
- Spent on programs
- 75%
- Reserves
- 17.5 months of spending
- Largest source of income
- donations and private grants, 95%
- Employees
- 7
- Volunteers
- 0
- Highest pay
- $231,253, institute director
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 80% of charities in its peer group (medical research, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 17.5 months of spending.
Debt
20 of 20It owes 1% of what it owns.
Living within its means
15 of 15Income exceeded spending by 35% of income.
Income trend
15 of 15Income rose 204% on the year before.
Spending floor
15 of 1575% of spending went to programs and raising each dollar of donations cost 11 cents.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 90 out of 100. Higher than 49% of charities in its peer group (medical research, $1m to $10m).
Independent board
25 of 253 of 5 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
0 of 10Did not give the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (11)
- $125,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $500,000 WITH EMORY UNIVERSITY. $125,000 OF THIS WAS FUNDED IN 2024.
- $175,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND A TOTAL OF $500,000 FOR CORRELATIVE STUDY AND TRANSLATIONAL SCIENCE GRANT WITH THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. $175,000 OF THIS WAS FUNDED IN 2024.
- $306,500 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND TWO GRANTS FOR A TOTAL OF $1,300,000 FOR A CLINICAL TRIAL AND CORRELATIVE STUDY WITH THE DANA FARBER CANCER INSTITUTE. $306,500 OF THIS WAS FUNDED IN 2024.
- $283,333 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL RESEARCH GRANT FOR A TOTAL OF $500,000 WITH BC CANCER. $283,333 OF THIS GRANT WAS FUNDED IN 2024.
- $125,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL RESEARCH GRANT FOR A TOTAL OF $500,000 WITH EUROPEAN MOLECULAR BIOLOGY LABORATORY. $125,000 OF THIS GRANT WAS FUNDED IN 2024.
- $125,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL RESEARCH GRANT FOR A TOTAL OF $500,000 WITH NORTHWESTERN UNIVERSITY. $125,000 OF THIS GRANT WAS FUNDED IN 2024.
- $110,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND CORRELATIVE STUDIES FOR A TOTAL OF $220,000 WITH STANFORD UNIVERSITY. $110,000 OF THIS GRANT WAS FUNDED IN 2024.
- $101,411 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $401,411 WITH UNIVERSITY OF MINNESOTA. $101,411 OF THIS WAS FUNDED IN 2024.
- $125,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $500,000 WITH BAYLOR COLLEGE OF MEDICINE. $125,000 OF THIS WAS FUNDED IN 2024.
- $125,000 spent. THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $500,000 WITH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY. $125,000 OF THIS WAS FUNDED IN 2024.
- $411,713 spent. OTHER PROGRAM SERVICES EXPENDITURES NOT DIRECTLY ALLOCABLE TO THE TWELVE ON-GOING RESEARCH GRANTS DURING THE CURRENT YEAR INCLUDING EXPENDITURES OF $18,821 FOR THE OSI CONNECT PROGRAM. THE OSI CONNECT PROGRAM IS A FREE, PATIENT-CENTERED SERVICE OFFERED BY THE OSTEROSARCOMA INSTITUTE THAT CONNECTS INDIVIDUALS AFFECTED BY OSTEOSARCOMA WITH EXPERT PHYSICIANS TO ANSWER QUESTIONS ABOUT THE DISEASE. THE NEGATIVE $100,000 WAS A RETURN OF A GRANT PAYMENT ASSOCIATED WITH A CANCELED GRANT FROM 2023.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since May 2018.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.